Metabolic Effects of Endoscopic Duodenal Mucosal Resurfacing: a Systematic Review and Meta-analysis

Imagem de Miniatura
Arquivos
art_OLIVEIRA_Metabolic_Effects_of_Endoscopic_Duodenal_Mucosal_Resurfacing_a_2021.PDF (998.18 KB)
Citações na Scopus
21
Tipo de produção
article
Data de publicação
2021
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
MCCARTY, Thomas R.
Citação
OBESITY SURGERY, v.31, n.3, p.1304-1312, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Duodenal mucosal resurfacing (DMR) is an innovative endoscopic bariatric and metabolic therapy (EBMT) emerging in recent years. It uses the duodenum to achieve better glycemic and weight control. This study aimed to evaluate in a critical and systematic way the metabolic effects of this procedure. Electronic searches were performed evaluating the DMR procedure based on predefined inclusion and exclusion criteria. Changes in measured outcomes were evaluated using random-effects models by computing weighted mean differences (MD) and corresponding 95% CIs between pre-and post-procedure metabolic characteristics. Four studies were selected for qualitative and quantitative analysis. DMR demonstrated beneficial glycemic and hepatic metabolic effects among patients with non-insulin dependent type 2 diabetes (T2D) at 3 and 6 months post-procedure.
Palavras-chave
Duodenal mucosal resurfacing, DMR, Diabetes, Hydrothermal ablation, Hepatic steatosis, Systematic review
URI
https://observatorio.fm.usp.br/handle/OPI/40071
Referências
  1. Aithal G, 2019, J HEPATOL, V70, pE70, DOI 10.1016/S0618-8278(19)30124-0
  2. Aldoheyan T, 2017, SURG ENDOSC, V31, P1142, DOI 10.1007/s00464-016-5082-8
  3. Buhmann H, 2014, BEST PRACT RES CL GA, V28, P559, DOI 10.1016/j.bpg.2014.07.003
  4. Caussy C, 2018, HEPATOLOGY, V68, P763, DOI 10.1002/hep.29797
  5. Cherrington Alan D, 2017, Gastrointest Endosc Clin N Am, V27, P299, DOI 10.1016/j.giec.2016.12.002
  6. Davies NK, 2019, SURG OBES RELAT DIS, V15, P656, DOI 10.1016/j.soard.2019.01.033
  7. Neto AAD, 2020, OBES SURG, V30, P1971, DOI 10.1007/s11695-020-04449-9
  8. de Moura EGH, 2019, ENDOSC INT OPEN, V7, pE685, DOI 10.1055/a-0862-0263
  9. Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585
  10. Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039
  11. Gerhard GS, 2013, DIABETES CARE, V36, P1859, DOI 10.2337/dc12-2255
  12. Hartemink N, 2006, AM J EPIDEMIOL, V163, P1042, DOI 10.1093/aje/kwj141
  13. Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
  14. Moura EGH, 2019, OBES SURG, V29, P32, DOI 10.1007/s11695-018-3470-y
  15. Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
  16. Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
  17. Magee C, 2018, GUT, V67, pA32, DOI 10.1136/gutjnl-2018-BSGAbstracts.61
  18. McCarty Thomas R, 2020, Tech Innov Gastrointest Endosc, V22, P145, DOI 10.1016/j.tige.2020.03.008
  19. Mingrone G, 2020, DIABETES, V69, DOI 10.2337/db20-121-LB
  20. MRAZ M, 2019, DIABETES S1, V68, DOI 10.2337/DB19-1131-P
  21. Mudaliar S, 2012, DIABETOLOGIA, V55, P1865, DOI 10.1007/s00125-012-2561-x
  22. Nauck MA, 2018, DIABETES OBES METAB, V20, P5, DOI 10.1111/dom.13129
  23. Neto MG, 2016, GASTROENTEROLOGY, V150, pS174, DOI 10.1016/S0016-5085(16)30672-2
  24. Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034
  25. Rajagopalan H, 2016, DIABETES CARE, V39, P2254, DOI 10.2337/dc16-0383
  26. Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b
  27. Kotinda APST, 2020, OBES SURG, V30, P2743, DOI 10.1007/s11695-020-04558-5
  28. Schauer PR, 2003, T M AM SURG ASS, V121, P160
  29. Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427
  30. Sherifali D, 2010, DIABETES CARE, V33, P1859, DOI 10.2337/dc09-1727
  31. Starekova J, 2020, ABDOM RADIOL, V45, P3386, DOI 10.1007/s00261-020-02783-1
  32. Sterne JA, 2016, BMJ
  33. The GRADE Working Group, 2015, GRADEPRO GUID DEV TO
  34. van Baar AC, 2017, UNITED EUR GASTROENT, pA161, DOI [10.1177/2050640617725676, DOI 10.1177/2050640617725676]
  35. van Baar ACG, 2018, UNITED EUR GASTROENT, pA135, DOI [10.1177/2050640618792819, DOI 10.1177/2050640618792819]
  36. van Baar A, 2019, GASTROINTEST ENDOSC, V89, pAB260, DOI 10.1016/j.gie.2019.03.293
  37. van Baar Annieke C G, 2019, JHEP Rep, V1, P429, DOI 10.1016/j.jhepr.2019.10.006
  38. van Baar ACG, 2020, GUT, V69, P295, DOI 10.1136/gutjnl-2019-318349
  39. Van Baar ACG, 2018, GASTROENTEROLOGY, V154, P773, DOI 10.1053/j.gastro.2018.02.010
  40. van Olst N, 2020, TECH INNOV GASTROINT, V22, P109, DOI [10.1016/j.tige.2020.03.003, DOI 10.1016/J.TIGE.2020.03.003]
  41. Verdam FJ, 2011, J CLIN ENDOCR METAB, V96, pE379, DOI 10.1210/jc.2010-1333
  42. Vilar-Gomez E, 2018, J HEPATOL, V68, P305, DOI 10.1016/j.jhep.2017.11.013
  43. Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
  44. World Health Organization, 2020, OB OV
  45. World Health Organization, 2020, DIABETES

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/35
Artigos e Materiais de Revistas Científicas - LIM/47
Artigos e Materiais de Revistas Científicas - ODS/03